CP

Chintan Pravinchandra Shah

Active Director Director DIN 09278999
DIN 09278999 First appointment Aug 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2021
Shareholding value •••• Premium profile

About Chintan Pravinchandra Shah

Data last updated:

Chintan Pravinchandra Shah is a Director at Clarane Pharma Private Limited (since 2021). The company operates in Chemicals. Clarane Pharma Private Limited reported revenue of ₹10.6 Lakh (FY 2025).

DIN 09278999
Primary Designation Director
Industry Chemicals
First Appointment 12 Aug 2021
Oldest Company Age 5 yrs
Largest company Clarane Pharma Private Limited · ₹10.6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Clarane Pharma Private Limited U24230GJ2021PTC124860
Director12 Aug 20212021₹10.6 Lakh (FY 2025)Active

Board colleagues of Chintan Pravinchandra Shah

Directorship timeline

Open interactive timeline →
Clarane Pharma Private Limited
Premium access

Shareholding and investment profile for Chintan Pravinchandra Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chintan Pravinchandra Shah

Chintan Pravinchandra Shah currently holds 1 directorship: Clarane Pharma Private Limited (Director, since 12 Aug 2021, revenue ₹10.6 Lakh (FY 2025)).

Chintan Pravinchandra Shah was first appointed on 12 Aug 2021 as Director at Clarane Pharma Private Limited.

The current boards of Chintan Pravinchandra Shah's companies include Mona Chintan Shah (Clarane Pharma Private Limited), Pravin Chandra Shah (Clarane Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available